Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere

Living with chronic kidney disease (CKD) is associated with hardships for patients and their care-partners. Empowering patients and their care-partners, including family members or friends involved in their care, may help minimize the burden and consequences of CKD related symptoms to enable life participation. There is a need to broaden the focus on living well with kidney disease and re-engagement in life, including an emphasis on patients being in control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 the year of “Living Well with Kidney Disease” in an effort to increase education and awareness on the important goal of patient empowerment and life participation. This calls for the development and implementation of validated patient-reported outcome measures to assess and address areas of life participation in routine care. It could be supported by regulatory agencies as a metric for quality care or to support labelling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients. Patients with kidney disease and their care-partners should feel supported to live well through concerted efforts by kidney care communities including during pandemics. In the overall wellness program for kidney disease patients, the need for prevention should be reiterated. Early detection with a prolonged course of wellness despite kidney disease, after effective secondary and tertiary prevention programs, should be promoted. WKD 2021 continues to call for increased awareness of the importance of preventive measures throughout populations, professionals, and policymakers, applicable to both developed and developing countries.

1. Tong A, Manns B, Wang AYM, et al. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney Int 2018;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. PubMed PMID: 30360959; PMCID: PMC6620755. URL: https://www.ncbi.nlm.nih.gov/pubmed/30360959

2. Carter SA, Gutman T, Logeman C et al,. Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers. Clin J Am Soc Nephrol 2020;15(5):673-684. doi: 10.2215/CJN.13101019. PubMed PMID: 32354728; PMCID: PMC7269216. URL: https://www.ncbi.nlm.nih.gov/pubmed/32354728

3. Hanson CS, Craig JC, Logeman C et al. Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology-Children and Adolescents (SONG-KIDS) consensus workshops. Kidney Int 2020. doi: 10.1016/j.kint.2020.05.054. PubMed PMID: 32628942. URL: https://www.ncbi.nlm.nih.gov/pubmed/32628942

4. Gonzalez AM, Gutman T, Lopez-Vargas P et al. Patient and caregiver priorities for outcomes in CKD: a multinational nominal group technique study. Am J Kid Di 2020. doi: 10.1053/j.ajkd.2020.03.022. Online ahead of print. doi. PubMed PMID

5. WHO. Towards a common language for functioning, disability and health. 2002;WHO/EIP/GPE/CAS/01.3

6. WHO. Health Promotion Glossary. 1998;WHO/HPR/HEP/98.1

7. Baumgart A, Manera KE, Johnson DWP et al. Meaning of empowerment in peritoneal dialysis: focus groups with patients and caregivers. Nephrol Dial Transplant 2020. doi: 10.1093/ndt/ gfaa127. PubMed PMID: 32712672. URL: https://www.ncbi.nlm.nih.gov/pubmed/32712672

8. PCORI. The Value of Engagement (Available at https:// www.pcori.org/about-us/our-programs/engagement/publicand-patient-engagement/value-engagement, accessed 1st September 2020). 2018

9. Bonventre JV, Hurst FP, West M et al. Technology Roadmap for Innovative Approaches to Kidney Replacement Therapies: A Catalyst for Change. Clin J Am Soc Nephrol 2019;14(10):1539-1547. doi: 10.2215/CJN.02570319. PubMed PMID: 31562182; PMCID: PMC6777588. URL: https://www.ncbi.nlm.nih.gov/pubmed/31562182

10. Ibrahim N, Michail M,d Callaghan P. The strengths based approach as a service delivery model for severe mental illness: a meta-analysis of clinical trials. BMC Psychiatry 2014;14:243. doi: 10.1186/s12888-014-0243-6. PubMed PMID: 25189400; PMCID: PMC4154523. URL: https://www.ncbi.nlm.nih.gov/pubmed/25189400

11. Parham R, Jacyna N, Hothi D et al. Development of a measure of caregiver burden in paediatric chronic kidney disease: The Paediatric Renal Caregiver Burden Scale. Journal of health psychology 2014. doi: 10.1177/1359105314524971. PubMed PMID: 24648321. URL: http://www.ncbi.nlm.nih.gov/pubmed/24648321

12. Subramanian L, Kirk R, Cuttitta T et al. A Qualitative Study of Patient, Care Partner, and Clinician Perceptions and Priorities in the United States and the United Kingdom. Kidney Med 2019;1(6):354-365. doi: 10.1016/j.xkme.2019.07.014. PubMed PMID: 32734216; PMCID: PMC7380395. URL: https://www.ncbi.nlm.nih.gov/pubmed/32734216

13. Angwenyi V, Aantjes C, Kajumi M et al. Patients experiences of self-management and strategies for dealing with chronic conditions in rural Malawi. PLoS One 2018;13(7):e0199977. doi: 10.1371/journal.pone.0199977. PubMed PMID: 29965990; PMCID: PMC6028088. URL: https://www.ncbi.nlm.nih.gov/pubmed/29965990

14. Ulasi II and Ijoma CK. The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in South-East Nigeria. J Trop Med 2010;2010:501957. doi: 10.1155/2010/501957. PubMed PMID: 20613945; PMCID: PMC2896838. URL: https://www.ncbi.nlm.nih.gov/pubmed/20613945

15. Spinowitz B, Pecoits-Filho R, Winkelmayer WC et al. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. J Med Econ 2019;22(6):593-604. doi: 10.1080/13696998.2019.1588738. PubMed PMID: 30813807. URL: https://www.ncbi.nlm.nih.gov/pubmed/30813807

16. Sukul N, Speyer E, Tu C et al. Pruritus and Patient Reported Outcomes in Non-Dialysis CKD. Clin J Am Soc Nephrol 2019;14(5):673-681. doi: 10.2215/CJN.09600818. PubMed PMID: 30975656; PMCID: PMC6500934. URL: https://www.ncbi.nlm.nih.gov/pubmed/30975656

17. Gregg LP and Hedayati SS. Pharmacologic and psychological interventions for depression treatment in patients with kidney disease. Curr Opin Nephrol Hypertens 2020;29(5):457-464. doi: 10.1097/MNH.0000000000000629. PubMed PMID: 32701597. URL: https://www.ncbi.nlm.nih.gov/pubmed/32701597

18. Li PK, Garcia-Garcia G, Lui SF et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. Kidney Int 2020;97(2):226-232. doi: 10.1016/j. kint.2019.12.002. PubMed PMID: 31980067. URL: https://www.ncbi.nlm.nih.gov/pubmed/31980067

19. Kalantar-Zadeh K and Li PK. Strategies to prevent kidney disease and its progression. Nat Rev Nephrol 2020;16(3):129-130. doi: 10.1038/s41581-020-0253-1. PubMed PMID: 32005966. URL: https://www.ncbi.nlm.nih.gov/pubmed/32005966.

20. Kalantar-Zadeh K, Wightman A and Liao S. Ensuring Choice for People with Kidney Failure – Dialysis, Supportive Care, and Hope. N Engl J Med 2020;383(2):99-101. doi: 10.1056/ NEJMp2001794. PubMed PMID: 32640129. URL: https://www.ncbi.nlm.nih.gov/pubmed/32640129